The Inogen At Home is expected to be the lightest 5l per minute continuous flow oxygen concentrator on the market, when it is released for sale later 2014.
At approximately 18 pounds, the Inogen At Home will be more than 10-20 pounds lighter than current oxygen concentrators from leading manufacturers with equivalent flow capacity.
Additionally, the Inogen At Home is expected to have the lowest power consumption of any 5l per minute continuous flow oxygen concentrator on the market, which should reduce the electricity cost for oxygen therapy patients. Other advancements made in the product include size and noise level reductions.
Inogen CEO Raymond Huggenberger said that the company set out to change the oxygen therapy market with its Inogen One family of products and in a similar fashion with the Inogen At Home, the company intends to change the perception of oxygen concentrators used in the home.
"We believe we have created a home concentrator with product attributes that will be patient preferred," Huggenberger added.
Inogen’s release of the Inogen At Home combined with their award winning Inogen One family of products positions the company with a complete product portfolio able to fulfill the clinical requirements of most oxygen therapy patients.
While the Inogen One product line is clinically validated for 24/7 use, the Inogen At Home gives Inogen a compelling solution for nocturnal-only oxygen therapy patients that do not yet require a portable solution.
The Inogen At Home is planned to be released for sale later 2014.
